PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

Adverum Biotechnologies, Inc. (ADVM)

Equity · Currency in USD · Last updated Feb 24, 2024
SummaryFinancials

Company Info

ISINUS00773U1088
CUSIP00773U108
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$208.62M
EPS-$1.26
Revenue (TTM)$3.60M
Gross Profit (TTM)-$81.68M
EBITDA (TTM)-$120.61M
Year Range$0.68 - $2.97
Target Price$4.20
Short %1.23%
Short Ratio1.65

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in Adverum Biotechnologies, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%40.00%60.00%80.00%SeptemberOctoberNovemberDecember2024February
25.00%
15.50%
ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ADVM

Adverum Biotechnologies, Inc.

Return

Adverum Biotechnologies, Inc. had a return of 165.67% year-to-date (YTD) and 185.71% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date165.67%6.69%
1 month120.02%4.52%
6 months25.00%15.50%
1 year185.71%26.83%
5 years (annualized)-11.59%12.76%
10 years (annualized)N/A10.70%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202439.48%
202337.11%-20.18%-13.79%-40.27%-9.74%-6.91%

Risk-Adjusted Performance

This table presents risk-adjusted performance metrics for Adverum Biotechnologies, Inc. (ADVM) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ADVM
Adverum Biotechnologies, Inc.
1.94
^GSPC
S&P 500
2.23

Sharpe Ratio

The current Adverum Biotechnologies, Inc. Sharpe ratio is 1.94. A Sharpe ratio greater than 1.0 is considered acceptable.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2024February
1.94
2.23
ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)

Dividend History


Adverum Biotechnologies, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2024February
-96.67%
0
ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Adverum Biotechnologies, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Adverum Biotechnologies, Inc. was 99.10%, occurring on Dec 27, 2022. The portfolio has not yet recovered.

The current Adverum Biotechnologies, Inc. drawdown is 96.67%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.1%Jan 8, 20152007Dec 27, 2022
-19.26%Aug 1, 20143Aug 5, 20149Aug 18, 201412
-17.74%Sep 30, 20149Oct 10, 201417Nov 4, 201426
-12.89%Sep 15, 20145Sep 19, 20145Sep 26, 201410
-10.31%Nov 5, 201411Nov 19, 20144Nov 25, 201415

Volatility Chart

The current Adverum Biotechnologies, Inc. volatility is 65.70%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%70.00%SeptemberOctoberNovemberDecember2024February
65.70%
3.90%
ADVM (Adverum Biotechnologies, Inc.)
Benchmark (^GSPC)